These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 31993450)
1. Antimalarial Properties of Isoquinoline Derivative from Nugraha RY; Faratisha IF; Mardhiyyah K; Ariel DG; Putri FF; Nafisatuzzamrudah ; Winarsih S; Sardjono TW; Fitri LE Biomed Res Int; 2020; 2020():6135696. PubMed ID: 31993450 [TBL] [Abstract][Full Text] [Related]
2. Metabolite extract of Streptomyces hygroscopicus Hygroscopicus inhibit the growth of Plasmodium berghei through inhibition of ubiquitin - proteasome system. Rivo YB; Alkarimah A; Ramadhani NN; Cahyono AW; Laksmi DA; Winarsih S; Fitri LE Trop Biomed; 2013 Jun; 30(2):291-300. PubMed ID: 23959495 [TBL] [Abstract][Full Text] [Related]
3. Fractions 14 and 36K of Metabolite Extract Fitri LE; Endharti AT; Abidah HY; Khotimah ARH; Endrawati H Infect Drug Resist; 2023; 16():2973-2985. PubMed ID: 37201124 [TBL] [Abstract][Full Text] [Related]
4. 1,2,3-Triazole derivatives: synthesis, docking, cytotoxicity analysis and in vivo antimalarial activity. Valério Lopes F; Fazza Stroppa PH; Marinho JA; Reis Soares R; de Azevedo Alves L; Capriles Goliatt PVZ; Abramo C; David da Silva A Chem Biol Interact; 2021 Dec; 350():109688. PubMed ID: 34627786 [TBL] [Abstract][Full Text] [Related]
5. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum. Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592 [TBL] [Abstract][Full Text] [Related]
6. Effect of Metabolite Extract of Fitri LE; Alkarimah A; Cahyono AW; Lady WN; Endharti AT; Nugraha RYB Iran J Parasitol; 2019; 14(3):444-452. PubMed ID: 31673263 [TBL] [Abstract][Full Text] [Related]
7. Identification of novel PfDHODH inhibitors as antimalarial agents via pharmacophore-based virtual screening followed by molecular docking and in vivo antimalarial activity. Vyas VK; Qureshi G; Ghate M; Patel H; Dalai S SAR QSAR Environ Res; 2016 Jun; 27(6):427-40. PubMed ID: 27310104 [TBL] [Abstract][Full Text] [Related]
9. In silico prediction and in vitro assessment of novel heterocyclics with antimalarial activity. Orozco MI; Moreno P; Guevara M; Abonia R; Quiroga J; Insuasty B; Barreto M; Burbano ME; Crespo-Ortiz MDP Parasitol Res; 2023 Dec; 123(1):75. PubMed ID: 38155300 [TBL] [Abstract][Full Text] [Related]
10. Apicoplast Import Protein Tic20 A Promising Therapeutic Molecular Target for Plasmodium falciparum: An In Silico Approach for Therapeutic Intervention. C P K Srimath-Tirumala-Peddinti R; Kusuma SS; Nammi D; Neelapu NRR Infect Disord Drug Targets; 2017; 17(3):199-222. PubMed ID: 28595540 [TBL] [Abstract][Full Text] [Related]
11. Targeting antimalarial metabolites from the actinomycetes associated with the Red Sea sponge Callyspongia siphonella using a metabolomic method. Gamaleldin NM; Bahr HS; Millán-Aguiñaga N; Danesh M; Othman EM; Dandekar T; Hassan HM; Abdelmohsen UR BMC Microbiol; 2023 Dec; 23(1):396. PubMed ID: 38087203 [TBL] [Abstract][Full Text] [Related]
12. In Silico Studies of Four Compounds of Lobato-Tapia CA; Moreno-Hernández Y; Olivo-Vidal ZE Molecules; 2023 Oct; 28(19):. PubMed ID: 37836757 [TBL] [Abstract][Full Text] [Related]
13. Pyrazole based Furanone Hybrids as Novel Antimalarial: A Combined Experimental, Pharmacological and Computational Study. Choudhary D; Rani I; Monga J; Goyal R; Husain A; Garg P; Khokra SL Cent Nerv Syst Agents Med Chem; 2022; 22(1):39-56. PubMed ID: 35232355 [TBL] [Abstract][Full Text] [Related]
14. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps. Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304 [TBL] [Abstract][Full Text] [Related]
15. New approaches in antimalarial drug discovery and development: a review. Aguiar AC; Rocha EM; Souza NB; França TC; Krettli AU Mem Inst Oswaldo Cruz; 2012 Nov; 107(7):831-45. PubMed ID: 23147137 [TBL] [Abstract][Full Text] [Related]
16. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial. Gaur AH; McCarthy JS; Panetta JC; Dallas RH; Woodford J; Tang L; Smith AM; Stewart TB; Branum KC; Freeman BB; Patel ND; John E; Chalon S; Ost S; Heine RN; Richardson JL; Christensen R; Flynn PM; Van Gessel Y; Mitasev B; Möhrle JJ; Gusovsky F; Bebrevska L; Guy RK Lancet Infect Dis; 2020 Aug; 20(8):964-975. PubMed ID: 32275867 [TBL] [Abstract][Full Text] [Related]
17. [Resistance to the antimalarial drugs]. Venanzi E; López-Vélez R Rev Esp Quimioter; 2016 Sep; 29 Suppl 1():72-5. PubMed ID: 27608319 [TBL] [Abstract][Full Text] [Related]
18. In silico identification of promiscuous scaffolds as potential inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase for treatment of Falciparum malaria. Wadood A; Ghufran M; Hassan SF; Khan H; Azam SS; Rashid U Pharm Biol; 2017 Dec; 55(1):19-32. PubMed ID: 27650666 [TBL] [Abstract][Full Text] [Related]
19. The de novo selection of drug-resistant malaria parasites. White NJ; Pongtavornpinyo W Proc Biol Sci; 2003 Mar; 270(1514):545-54. PubMed ID: 12641911 [TBL] [Abstract][Full Text] [Related]
20. Plasmodial Kinase Inhibitors: License to Cure? Cabrera DG; Horatscheck A; Wilson CR; Basarab G; Eyermann CJ; Chibale K J Med Chem; 2018 Sep; 61(18):8061-8077. PubMed ID: 29771541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]